Virpax Pharmaceuticals prices $40M public stock offering
September 15, 2021 at 13:22 PM EDT
The company plans to use the proceeds to advance its non-opioid and non-addictive pain management products.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |